Literature DB >> 14567239

Chemical immobilization of crested porcupines with tiletamine HCl and zolazepam HCl (Zoletil) under field conditions.

Alessandro Massolo1, Andrea Sforzi, Sandro Lovari.   

Abstract

The combination of tiletamine HCl and zolazepam HCl has been used on many species of wild mammals. Short induction time, low dosage, satisfactory safety margins, relatively constant immobilization time, and smooth recovery are benefits reported. This combination (Zoletil 100) was used during a study on behavioural ecology of the crested porcupine (Hystrix cristata) in a Mediterranean coastal area (Maremma Regional Park, Tuscany, Italy). We used this mixture 42 times on 31 individuals. Mean adult dose was (+/- SE) 7.24 +/- 0.37 mg/kg (74.0 +/- 3.0 mg/individual). Average adult induction time was 5.3 min (+/- 1.1) and average adult immobilization time was 22.6 min (+/- 6.0). One adult male porcupine died after chemical restraints. The use of tiletamine-zolazepam seems adequate for chemical immobilization of crested porcupines under field conditions, mainly because of its short induction time, small volume to be injected and wide safety margin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14567239     DOI: 10.7589/0090-3558-39.3.727

Source DB:  PubMed          Journal:  J Wildl Dis        ISSN: 0090-3558            Impact factor:   1.535


  3 in total

1.  Ectoparasite load in the crested porcupine Hystrix cristata Linnaeus, 1758 in Central Italy.

Authors:  Emiliano Mori; Andrea Sforzi; Mattia Menchetti; Giuseppe Mazza; Sandro Lovari; Benoît Pisanu
Journal:  Parasitol Res       Date:  2015-03-17       Impact factor: 2.289

2.  Field Chemical Immobilization of Free-Ranging Crested Porcupines with Zoletil®: A Reviewed Dosage.

Authors:  Francesca Coppola; Enrico D'Addio; Lucia Casini; Simona Sagona; Antonio Felicioli
Journal:  Vet Sci       Date:  2020-12-01

3.  Chemical immobilization of adult female Weddell seals with tiletamine and zolazepam: effects of age, condition and stage of lactation.

Authors:  Kathryn E Wheatley; Corey J A Bradshaw; Robert G Harcourt; Lloyd S Davis; Mark A Hindell
Journal:  BMC Vet Res       Date:  2006-02-09       Impact factor: 2.741

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.